Meetings and Correspondence on Marketing and Advertising of Opioids

The following table includes correspondence and meetings with stakeholders in which views, opinions and information are relayed with the intent to inform the development of policies, guidance or regulations related to the restriction of marketing and advertising of opioids.

Responses to formal consultations and communication for the purposes of making simple enquiries or requests for information that do not have any relevance, in Health Canada's view, to the development of policies related to restricting the marketing and advertising of opioids are not included.

For more information on Health Canada's transparency policy when communicating with stakeholders, please see the Transparency of Stakeholder Communications for Marketing and Advertising of Opioids Initiatives page.

You can request copies of correspondence and documents shared as part of stakeholder meetings. Please note that any documents requested will be provided in the official language in which the entity submitted them to Health Canada.

The last update was done on March 26, 2019.

To view only the correspondence received in response to the Minister of Health's letter to manufacturers and distributors of opioids in Canada requesting that they respond to the opioid crisis by immediately suspending any and all marketing and advertising of opioids to health care professionals on a voluntary basis, please see the Response to the Call on the Pharmaceutical Industry to Voluntarily Suspend Marketing and Advertising of Opioids summary table.

Date Topic Organization Type of Interaction Purpose Health Canada Office Documents Shared Order a Copy
2018-06-19 Marketing and Advertising of Opioids Canadian opioid manufacturers and distributors Heath Canada-Initiated Correspondence To seek commitment to immediately suspend marketing and advertising of opioids to health care professionals. Minister of Health

Minister of Health Letter to Industry
List of firms that were sent a letter

2018-06-19 Marketing and Advertising of Opioids Aralez Pharmaceuticals Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Aralez Pharmaceuticals Canada Inc.
2018-06-20 Marketing and Advertising of Opioids Biomed Pharma Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Biomed Pharma
2018-06-21 Marketing and Advertising of Opioids Mint Pharmaceuticals Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Mint Pharmaceuticals Inc.
2018-06-21 Marketing and Advertising of Opioids Ranbaxy Pharmaceuticals Canada Inc. a SUN PHARMA Company Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Ranbaxy Pharmaceuticals Canada Inc. a SUN PHARMA Company
2018-06-22 Marketing and Advertising of Opioids INDIVIOR Canada Ltd. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals. Minister of Health Letter - INDIVIOR Canada Ltd.
2018-06-26 Marketing and Advertising of Opioids Shire Pharma Canada ULC Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Shire Pharma Canada ULC
2018-06-26 Marketing and Advertising of Opioids Aspen Pharmacare Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Aspen Pharmacare Canada Inc.
2018-06-26 Marketing and Advertising of Opioids Teva Canada Limited Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Teva Canada Limited
2018-06-27 Marketing and Advertising of Opioids Purdue Pharma Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Purdue Pharma
2018-06-27 Marketing and Advertising of Opioids Paladin Labs Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Paladin Labs Inc.
2018-06-27 Marketing and Advertising of Opioids AstraZeneca Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - AstraZeneca Canada Inc.
2018-06-29 Marketing and Advertising of Opioids Sandoz Canada Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Sandoz Canada
2018-06-29 Marketing and Advertising of Opioids Ethypharm Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Ethypharm
2018-07-03 Marketing and Advertising of Opioids Ontario Pain Foundation Stakeholder-Initiated Correspondence To communicate views on restricting the marketing and advertising of opioids to health care professionals Minister of Health Letter - Ontario Pain Foundation
2018-07-05 Marketing and Advertising of Opioids Innovative Medicines Canada Stakeholder-Initiated Meeting To learn about Health Canada's proactive monitoring of advertising and transparency initiatives related to the marketing and advertising of opioids Health Products and Food Branch Agenda Meeting Report - Innovative Medicines Canada
2018-07-06 Marketing and Advertising of Opioids Pro Doc Ltée Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Pro Doc Ltée
2018-07-06 Marketing and Advertising of Opioids Teligent Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Teligent Canada Inc.
2018-07-09 Marketing and Advertising of Opioids Innovative Medicines Canada Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Innovative Medicines Canada
2018-07-11 Marketing and Advertising of Opioids Janssen Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Janssen Inc.
2018-07-13 Marketing and Advertising of Opioids Pfizer Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Pfizer Canada Inc.
2018-07-17 Marketing and Advertising of Opioids Canadian Generic Pharmaceutical Association Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Canadian Generic Pharmaceutical Association
2018-07-18 Marketing and Advertising of Opioids Sanofi-Aventis Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Sanofi-Aventis Canada Inc.
2018-07-19 Marketing and Advertising of Opioids Mylan Pharmaceuticals ULC (BGP Pharma ULC) Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Mylan Pharmaceuticals ULC (BGP Pharma ULC)
2018-07-26 Marketing and Advertising of Opioids AbbVie Corporation Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - AbbVie Corporation
2018-07-31 Marketing and Advertising of Opioids Allergan Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Allergan Inc.
2018-08-17 Marketing and Advertising of Opioids Canadian opioid manufacturers and distributors Heath Canada-Initiated Correspondence To seek commitment to immediately suspend marketing and advertising of opioids to health care professionals. Health Products and Food Branch

Letter to Industry
List of firms that were sent a letter

2018-08-20 Marketing and Advertising of Opioids Confab Laboratories Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Confab Laboratories Inc.
2018-09-04 Marketing and Advertising of Opioids Vita Health Products Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Vita Health Products Inc.
2018-09-06 Marketing and Advertising of Opioids Hospira Healthcare Corporation, a Pfizer Company Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch

Letter - Hospira Healthcare Corporation, a Pfizer Company

Letter - Pfizer Canada Inc.
2018-09-06 Marketing and Advertising of Opioids Pfizer Consumer Healthcare, a Division of Pfizer Canada Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch

Letter - Pfizer Consumer Healthcare, a Division of Pfizer Canada Inc.

Letter - Pfizer Canada Inc.
2018-09-14 Marketing and Advertising of Opioids Teva Canada Limited Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Teva Canada Limited, Actavis Group PTC ehf., Actavis Pharma Company
2018-09-17 Marketing and Advertising of Opioids Bristol-Myers Squibb Canada Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Bristol-Myers Squibb Canada
2018-09-21 Marketing and Advertising of Opioids Pharmascience Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Pharmascience Inc.
2018-09-21 Marketing and Advertising of Opioids Pendopharm, a division of Pharmascience Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Pendopharm, a division of Pharmascience Inc.
2018-09-21 Marketing and Advertising of Opioids Dominion Pharmacal, a sister company of Pharmascience Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Dominion Pharmacal, a sister company of Pharmascience Inc.
2018-09-21 Marketing and Advertising of Opioids SteriMax Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - SteriMax Inc.
2018-09-27 Marketing and Advertising of Opioids Omega Laboratories Limited Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter - Omega Laboratories Limited
2018-10-11 Marketing and Advertising of Opioids INDIVIOR Canada Ltd. Stakeholder-Initiated Meeting To share feedback with Health Canada on potential restrictions related to the marketing and advertising of opioids Health Products and Food Branch Meeting Report - INDIVIOR Canada Ltd.
2018-11-29 Marketing and Advertising of Opioids Laboratoire Riva Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter – Laboratoire Riva Inc.
2018-12-04 Marketing and Advertising of Opioids Canadian Generic Pharmaceutical Association Bilateral meeting between the Health Products and Food Branch and the Canadian Generic Pharmaceutical Association To update on Health Canada's proposed restrictions on the marketing and advertising of opioids Health Products and Food Branch Item Summary - Canadian Generic Pharmaceutical Association
2018-12-21 Marketing and Advertising of Opioids AA Pharma Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Minister of Health Letter – AA Pharma Inc.
2019-01-31 Marketing and Advertising of Opioids Canadian opioid manufacturers and distributors Heath Canada-Initiated Correspondence To follow-up with non-responsive companies regarding the Minister of Health's request to immediately suspend marketing and advertising of opioids to health care professionals Health Products and Food Branch Health Canada Letter to Industry
List of firms that were sent the letter
2019-01-31 Marketing and Advertising of Opioids Marcan Pharmaceuticals Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter- Marcan Pharmaceuticals Inc.
2019-02-01 Marketing and Advertising of Opioids Endo Ventures Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter – Endo Ventures Inc.
2019-02-04 Marketing and Advertising of Opioids Church & Dwight Canada Corporation Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter – Church & Dwight Canada Corporation
2019-02-04 Marketing and Advertising of Opioids Pharmapar Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Pharmapar Inc.
2019-02-05 Marketing and Advertising of Opioids Sanis Health Inc. (Part of Shopper's Drug Mart). Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Sanis Health Inc. (Part of Shopper's Drug Mart)
2019-02-11 Marketing and Advertising of Opioids Sivem Pharmaceuticals ULC Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter - Sivem Pharmaceuticals ULC
2019-02-12 Marketing and Advertising of Opioids Laboratoire Atlas Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter – Laboratoire Atlas
2019-02-13 Marketing and Advertising of Opioids Apotex Inc. Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter – Apotex Inc.
2019-02-13 Marketing and Advertising of Opioids ICU Medical Canada Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter – ICU Medical Canada
2019-02-14 Marketing and Advertising of Opioids JAMP Pharma Corporation Stakeholder-Initiated Correspondence To respond to Health Canada-Initiated Correspondence seeking immediate suspension of marketing and advertising of opioids to health care professionals Health Products and Food Branch Letter – JAMP Pharma Corporation
2019-05-14 and 2019-05-15 Marketing and Advertising of Opioids Professional Regulatory Bodies and Health Care Professional Associations Stakeholder Engagement Session Seek views and feedback on opioid marketing and advertising Health Products and Food Branch Summary of discussion
2019-05-14 and 2019-05-15 Marketing and Advertising of Opioids Professional Regulatory Bodies and Health Care Professional Associations Stakeholder Engagement Session Seek views and feedback on opioid marketing and advertising Health Products and Food Branch Presentation

For more information

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: